Oncology Stakeholders Summit, Fall 2016

The Future of Value-Based Care and Payment Models in Cancer Care
February 13, 2017 – 
Rena M. Conti, PhD; Brenton Fargnoli, MD; and Andrew L. Pecora, MD, CPE, share final considerations about their expectations given the shift from fee-for-service to value-based care in oncology.
Do APMs Incorporate Survivorship Care in Oncology?
February 13, 2017 – 
Following a previous discussion on alternative payment models under healthcare reform and an increased focus on patient-centric care, Rena M. Conti, PhD; Brenton Fargnoli, MD; Andrew L. Pecora, MD, CPE; and Bhuvana Sagar, MD, remark on the importance of integrating survivorship planning into these new models.
Patient Centricity of Care Delivery and Payment Models
February 03, 2017 – 
In this segment, Rena M. Conti, PhD; Brenton Fargnoli, MD; Andrew L. Pecora, MD, CPE; and Bhuvana Sagar, MD, discuss how alternative payment models are being designed to focus on improving different aspects of patient care.
The Balancing Act of Healthcare Costs
February 03, 2017 – 
Rena M. Conti, PhD, and Andrew L. Pecora, MD, CPE, remark on pharmaceutical companiesí previous use of fixed-cost investing and its challenges under healthcare reform.
Innovative Technology and Healthcare Costs
January 27, 2017 – 
Rena M. Conti, PhD; Brenton Fargnoli, MD; and Andrew L. Pecora, MD, CPE, describe the financial variables that should be taken into consideration when investing in information technology resources for use in hospital and community healthcare settings.
Importance of Data Sharing in Healthcare
January 27, 2017 – 
Despite the potential benefits of sharing healthcare data, Rena M. Conti, PhD; Brenton Fargnoli, MD; and Andrew L. Pecora, MD, CPE; note that there are also several associated challenges. The panelists suggest that engaging patients to be responsible for their electronic health records can improve care.
Leveraging Health IT in Cancer Care
January 19, 2017 – 
Rena M. Conti, PhD; Brenton Fargnoli, MD; Andrew L. Pecora, MD, CPE; and Bhuvana Sagar, MD, highlight challenges regarding the use of current health information technology (IT) systems and share their expectations for the potential of IT use in oncology care after these issues are addressed.
Who Shares the Maximum Risk With Innovative Treatments in Oncology?
January 16, 2017 – 
Rena M. Conti, PhD; Brenton Fargnoli, MD; and Andrew L. Pecora, MD, CPE, discuss concerns regarding the use of newer therapies, specifically immuno-oncology agents, for the treatment of cancer. Among their considerations, they remark on the financial burden these agents place on various stakeholders and consider who should be responsible for treatment coverage.
Site of Service and the Challenge of Value-Based Care
January 09, 2017 – 
In this segment, Rena M. Conti, PhD; Brenton Fargnoli, MD; Andrew L. Pecora, MD, CPE; and Bhuvana Sagar, MD, discuss how the shift to value-based care in oncology is affecting both community practices and hospital-based care settings.
Risk-Based Contracting in Oncology
January 09, 2017 – 
Rena M. Conti, PhD, describes in what situations risk-based reimbursement models may work in the oncology setting as new initiatives, such as bundled-payment models, become more established in healthcare
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!